In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs), marking a quiet but significant shift in how we can track and understand our health. Devices like ...
This healthcare technology company is disrupting the diabetes market with innovative technologies that patients love. More than 34 million Americans have diabetes and an additional 88 million are at ...
DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback